Medeva and Georgetown win in SPC rulings
The Court of Justice of the EU clarified the law on SPCs for combination drugs this morning, but included a sting in the tail for pharma companies
Both pharmaceutical company Medeva and Georgetown University had applications for supplementary protection certificates (SPCs) rejected by the UK IPO.
When both were appealed at the Court of Appeal, the court referred several questions to the Court of Justice (CJ) on...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.